301 The Lupus Risk Index (LRI) as a biomarker in patients with lupus nephritis

• Cynthia Aranow,
• Betty Diamond,
• Yemil Atisha-Fregoso,
• Susan Malkiel,
• Ali Dalgish-Choi

Affiliations

Cynthia Aranow

Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, New York, USA

Betty Diamond

Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA

Yemil Atisha-Fregoso

The Feinstein Institute for Medical Research, Manhasset, New York, USA

Susan Malkiel

3Center for Autoimmune, Musculoskeletal, and Hematologic Diseases Research, Feinstein Institute for Medical Research, Manhasset, NY, USA

Ali Dalgish-Choi

Feinstein Institutes for Medical Research, New York, NY, United States